Categories for Uncategorized

30 Nov 2023 Dedalus and Ibex launch an end-to-end AI-powered digital pathology solution, streamlining cancer diagnosis across Europe

Read more

14 Nov 2023 Ibex Medical Analytics achieves HITRUST certification demonstrating the highest level of information protection assurance

Read more

26 Oct 2023 Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses

Read more

10 Oct 2023 CorePlus Shows Success With Real-World Utilization of Ibex’s AI Platform for Routine Cancer Diagnosis, Supporting Improved Patient Outcomes  

Read more

7 Sep 2023 Ibex Launches Galen™ Breast HER2, Supporting Improved Biomarker Scoring in Breast Cancer Patients

Read more

6 Sep 2023 Ibex Raises $55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis

Read more

9 Mar 2023 Ibex and Alverno Laboratories sign multi-year, multi-tissue expansion agreement of AI for cancer diagnosis

Read more

7 Mar 2023 Ibex secures PathLAKE contracts to roll out AI-based cancer diagnostics to UK hospitals

Read more

6 Mar 2023 Ibex scoops second win of the UK Artificial Intelligence Award with leading NHS trusts

Read more

9 Feb 2023 Ibex’s Galen™ Prostate becomes first standalone AI-powered cancer diagnostics solution to obtain CE mark under the IVDR

Read more

24 Jan 2023 Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product

Read more
Excellent Outcomes of Ibex’s AI Solution for Breast Cancer Detection

21 Dec 2022 Institut Curie study published in a Nature Journal reporting excellent outcomes of Ibex’s AI solution for breast cancer detection

Read more